Compare DCTH & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DCTH | AEYE |
|---|---|---|
| Founded | 1988 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 350.7M | 170.9M |
| IPO Year | N/A | N/A |
| Metric | DCTH | AEYE |
|---|---|---|
| Price | $10.35 | $9.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $22.60 | $22.00 |
| AVG Volume (30 Days) | ★ 505.0K | 112.7K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $79,603,000.00 | $39,540,000.00 |
| Revenue This Year | $131.69 | $16.79 |
| Revenue Next Year | $39.22 | $11.30 |
| P/E Ratio | $305.16 | ★ N/A |
| Revenue Growth | ★ 251.54 | 18.57 |
| 52 Week Low | $8.12 | $8.91 |
| 52 Week High | $18.23 | $20.57 |
| Indicator | DCTH | AEYE |
|---|---|---|
| Relative Strength Index (RSI) | 57.61 | 18.06 |
| Support Level | $9.69 | $9.43 |
| Resistance Level | $10.86 | $10.35 |
| Average True Range (ATR) | 0.33 | 0.47 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 57.26 | 2.90 |
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.